{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T22:41:00Z","timestamp":1759704060174,"version":"build-2065373602"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41440-025-02288-8","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T08:25:35Z","timestamp":1753431935000},"page":"2763-2765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From binary to gradient: EUS-RFA redefines primary aldosteronism therapy"],"prefix":"10.1038","volume":"48","author":[{"given":"Zhixin","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"2288_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1210\/endrev\/bnad026","volume":"45","author":"N Mullen","year":"2024","unstructured":"Mullen N, Curneen J, Donlon PT, Prakash P, Bancos I, Gurnell M, et al. Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks. Endocr Rev. 2024;45:125\u201370.","journal-title":"Endocr Rev"},{"key":"2288_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, et al. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of Aldosterone-producing adenoma. Hypertension. 2018;71:317\u201325.","journal-title":"Hypertension"},{"key":"2288_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41574-020-0382-4","volume":"16","author":"MC Zennaro","year":"2020","unstructured":"Zennaro MC, Boulkroun S, Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol. 2020;16:578\u201389.","journal-title":"Nat Rev Endocrinol"},{"key":"2288_CR4","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.jacc.2023.08.045","volume":"82","author":"DE Kandzari","year":"2023","unstructured":"Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder RE, et al. Safety and efficacy of renal denervation in patients taking antihypertensive medications. J Am Coll Cardiol. 2023;82:1809\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"2288_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.121.054318","volume":"144","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Liu X, Zhang H, Li Q, He H, Yan Z, et al. Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial. Circulation. 2021;144:580\u20132.","journal-title":"Circulation"},{"key":"2288_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3803\/EnM.2020.880","volume":"35","author":"BK Park","year":"2020","unstructured":"Park BK. Percutaneous adrenal radiofrequency ablation: a short review for endocrinologists. Endocrinol Metab. 2020;35:750\u20135.","journal-title":"Endocrinol Metab"},{"key":"2288_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(24)02755-7","volume":"405","author":"G Argentesi","year":"2025","unstructured":"Argentesi G, Wu X, Ney A, Goodchild E, Laycock K, Lee YN, et al. Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial. Lancet. 2025;405:637\u201347.","journal-title":"Lancet"},{"key":"2288_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders J, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689\u201399.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2288_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S2213-8587(24)00308-5","volume":"13","author":"J Yang","year":"2025","unstructured":"Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, et al. Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort. Lancet Diabetes Endocrinol. 2025;13:119\u201333.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2288_CR10","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1530\/EJE-22-0375","volume":"187","author":"SY Chen","year":"2022","unstructured":"Chen SY, Chen JY, Huang WC, Puar T, Chin KP, Chueh JS, et al. Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis. Eur J Endocrinol. 2022;187:S47\u201358.","journal-title":"Eur J Endocrinol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02288-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02288-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02288-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T22:19:26Z","timestamp":1759702766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02288-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2288"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02288-8","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"type":"print","value":"0916-9636"},{"type":"electronic","value":"1348-4214"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}